Sep 30, 2020, 02:49 by User Not Found

Clinical Research News | For Medable, a leading advocate of decentralized clinical trials (DCTs), COVID-19 attracted surprising if welcome attention to the idea of making studies more patient-centric. The pandemic helped grow company revenues 400% in the first half of 2020 and, in the estimation of CEO and co-founder Dr. Michelle Longmire (a Stanford-trained physician), accelerated DCT adoption by five years.

Sep 28, 2020, 14:45 by User Not Found

Clinical Research News | In assessing the impact of COVID-19 on clinical research and development, companies are considering a range of factors including the ability of patients to access medicines and travel to trial sites, whether patients might decline to participate in clinical research, potential changes in regulatory guidance, and resource allocation at trial sites.

Sep 25, 2020, 13:27 by User Not Found

Clinical Research News | Both Johns Hopkins and Mount Sinai release patient prediction models, Mass General publishes new blood test for patient stratification, two VA studies look at COVID-19 in vet populations, study shows widespread kidney damage with 30% of patients needing dialysis, and FDA issues a guidance for assessing COVID-19 symptoms in clinical trials. Plus, NIAID launches fourth clinical trial for a SARS-CoV-2 vaccine, NIH expands trials of convalescent plasma, and screening program launches for sub-Saharan Africa.

Sep 22, 2020, 01:00 by User Not Found

Clinical Research News | Elsevier has launched PatientPass, a cloud-based patient engagement platform integrated with the Epic Electronic Health Record (EHR) system using SMART on FHIR. The new platform will let clinicians choose and deliver highly personalized, actionable content to patients in several formats, including on their mobile phones and via SMS alerts.

Sep 18, 2020, 01:00 by User Not Found

Clinical Research News | COVID-19 will become seasonal (eventually), mental effects on children and pregnant women, gaps in vaccine interest, what’s behind disparities, a test to identify plasma donors, better way to measure deaths, thousands could have lasting nerve damage, what does and doesn’t put people at higher risk, reasons for rehospitalization, potential shortening of life expectancy, azithromycin okay by itself, and researchers question Russian vaccine while citizen scientists experiment with DIY ones. Plus, a backlog in oncology, AI put to work and seven digital health solutions get NIH funding.

Sep 17, 2020, 18:36 by

CATO SMS unveiled its new brand today, revealing an updated look and logo capturing the company’s powerful offering following the merger of CATO Research, LLC and Specialized Medical Services-oncology BV (SMS-oncology).

Sep 17, 2020, 18:35 by

Digital therapeutics leader Biofourmis closes $100 million Series C led by SoftBank. Funds will help accelerate virtual clinical trials business, among other initiatives.

Sep 17, 2020, 18:35 by

Global Genes and the Child Neurology Foundation, as part of the Rare Access to Critical Therapies (ACT) collaboration, announced today the joint release of a report highlighting and supporting guiding principles of rare disease care and access — which the groups assert are universally relevant to all patients with rare diseases.

Sep 17, 2020, 18:35 by

Litmus Health, the research-ready infrastructure platform for real world data, that you might find interesting. As a bit of background, Litmus collects real world data from wearables and sensors, and analyzes these data for inclusion in clinical trials for their customers in pharma. This morning, the company announced that after a thorough third party security assessment, its infrastructure was determined to be secure and compliant when measured against federal security regulations.

Sep 17, 2020, 18:32 by

Please see below for the latest news from APIS Assay Technologies Ltd announcing the acquisition of Beogenomics, a specialised software developer with major expertise in Bioinformatics and Artificial Intelligence (BIOX). Beogenomics develops both on-prem and secure cloud-based data analysis solutions — helping customers design, build and run custom tailored genomics & proteomics pipelines. The integration into Manchester-based APIS will support the launch of a new BIOX Service Line as part of the company’s ongoing Biomarker Research and Development activities.

Sep 17, 2020, 18:32 by

European Centre for Clinical Research Training (ECCRT) has been selected as a premium provider for continuous online learning by IDDI, a BIOSTATISTICAL AND ECLINICAL SERVICES provider for Pharmaceutical and Biotechnology companies. ECCRT will provide access to the eLearning ‘Virtual Campus’ platform that will allow IDDI’s global staff members to attend ICH Good Clinical Practice and related trainings.

Sep 17, 2020, 18:18 by

WEP Group Holdings Limited (WEP), a specialist CRO focused on delivering lifesaving drugs to patients that have an unmet clinical need, is expanding its capabilities by making a strategic investment in Wren Healthcare Limited (Wren), a successful and growing clinical nursing healthcare provider in the EU.

Sep 17, 2020, 18:18 by

CATO SMS announced today that it has acquired Wilmington, NC-based Array Biostatistics (Array) to expand its offering of specialized clinical research solutions.

Sep 17, 2020, 18:18 by

Sep 17, 2020, 18:18 by

Sep 17, 2020, 18:18 by

Sep 17, 2020, 18:18 by

The Huntington Study Group (“HSG”), a world leader in clinical research for Huntington’s Disease (HD), announces a partnership with Prilenia Therapeutics, a clinical stage biotech company led by Michael R. Hayden, MD, PhD, to conduct PRidopidine Outcome On Function in Huntington’s Disease (PROOF-HD) clinical study. PROOF-HD is a global Phase 3, randomized, double-blind, placebo-controlled, parallel arm, multicenter study evaluating the efficacy and safety of pridopidine in patients with early stage HD.

Sep 16, 2020, 07:16 by User Not Found

Clinical Research News | While non-COVID medical research, including clinical trials, has partially resumed after widespread suspensions, delays and slowdowns during the outbreak, subsequent waves of COVID-19 infections still threaten to re-occupy clinicians, researchers, and labs. Fortunately, adversity can trigger adaptation.

Sep 14, 2020, 09:22 by User Not Found

Clinical Research News | Big money to speed clinical trials for Freenome’s colorectal cancer blood test, both THREAD and Science37 get investments to advance decentralized research approaches for global clinical trials, and more.

Sep 11, 2020, 01:00 by User Not Found

Clinical Research News | NSAIDS are safe for COVID-19 patients, a CHOP study shows convalescent plasma appears safe and possibly effective for children, a Boston study shows very low rates of hospital transmission of COVID-19. Plus, NIH launches two Phase 3 trials for blood thinners, the International Vaccine Institute preps with Gates money, and Phesi warns that many clinical trial sites may not bounce back.